The latest business and people happenings, and COVID-19 response, from around the industry.
PRISYM ID has made changes to its senior leadership team. Life sciences and technology veteran Richard Adams has joined as Chief Executive Officer, and Lauren Patterson has been appointed Chief Financial Officer.
Advarra announced the appointment of Gadi Saarony as Chief Executive Officer.
MMS Holdings Inc. announced the addition of Kelly Vaillant as Director, Global Transparency Strategy and Compliance.
SGS Clinical Pharmacology Unit
SGS is supporting ZNA Stuivenberg Hospital, Antwerp in its fight against the COVID-19 pandemic by offering the use of its Clinical Pharmacology Unit, within the hospital, equipped with 88 beds. SGS has also donated Personal Protective Equipment, including 1,100 masks and 21,000 gloves.
WCG is providing access to a web resource, WCG COVID-19 Patient Insights Resource Center, dedicated to representing the voice, perspective, and needs of patients and study participants in clinical trials during the COVID-19 pandemic.
BioIVT announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy research.
Sharp Clinical has confirmed that it is involved in supporting six clinical trials related to COVID-19.
Syneos Health, supported by the Association of Clinical Research Organizations, has announced a volunteer program to enable clinically qualified employees to address the UK government’s call for volunteers to support COVID-19 testing.
CROMSOURCE announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company.
PPD, Inc. has been named by IDG’s CIO as a 2020 CIO 100 Awards honoree.
TrialScope’s “Real Patient Stories: The Trials of Finding Clinical Trials,” has won a Silver award in the WEGO Health Patient-Choice Awards for Most Authentic Use of Patients in a Marketing Campaign.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Arcus’ Quemliclustat Earns Orphan Drug Designation as Phase III Pancreatic Cancer Trial Advances
July 11th 2025The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the global PRISM-1 Phase III trial nears full enrollment following promising survival data from ARC-8.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.